Biological and Hormonal Therapies of CancerKenneth A. Foon, Hyman B. Muss Springer Science & Business Media, 1998 M01 31 - 286 páginas This volume, Biological and Hormonal Therapies of Cancer, which is part of the series Cancer Treatment and Research, presents selected new information concerning biologic and hormonal therapy of cancer. We have attempted to provide the reader with topics of major interest in a timely fashion. There is renewed interest in biologic therapy of cancer. Two chapters review the role of interferon in the hematologic malignancies and in solid tumors. Vaccine therapies have come to the forefront of cancer therapy re cently, and two chapters approach different strategies of vaccine therapies; one reviews the cellular vaccine therapies and another the anti-idiotype ap proach. The hormonal therapy chapters focus on current uses of endocrine therapy in endometrial, breast, and prostate cancer. In addition, hormonal strategies for the prevention of breast cancer and endometrial cancer, including excit ing information relating to phytochemicals, are presented. The effects of tamoxifen on endometrium is a topic of major interest and is discussed in detail. Finally, there is a chapter on estrogen receptor expression and regula tion in human breast cancer. These chapters are all written by experts in the field and contain timely and relevant information of interest to laboratory and clinical scientists and practitioners alike. Biologic and endocrine therapies represent major areas of cancer research interest. The advent of newer biologic therapies, including new antibody targeted treatments, and the use of biologics as tumor modulators to enhance the effects of other treatment regimens is an exploding avenue of research. |
Contenido
Interferon therapy of hematologic malignancies | 1 |
Interferon use in solid tumors | 23 |
Cellular vaccine therapies for cancer | 35 |
Antiidiotype antibody vaccine therapies of cancer | 51 |
Endocrine therapy of prostate cancer | 69 |
Endocrine therapy of endometrial cancer | 89 |
Phytochemicals for the prevention of breast and endometrial cancer | 107 |
Hormonal strategies for the prevention of breast cancer | 135 |
Ovarian ablation as adjuvant therapy for earlystage breast cancer | 159 |
The duration of adjuvant tamoxifen therapy | 181 |
Tamoxifen and the endometrium | 195 |
Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors | 209 |
Endocrine therapy in metastatic breast cancer | 231 |
The regulation of estrogen receptor expression and function in human breast cancer | 255 |
Otras ediciones - Ver todas
Biological and Hormonal Therapies of Cancer Kenneth A. Foon,Hyman B. Muss Vista previa limitada - 2012 |
Biological and Hormonal Therapies of Cancer Kenneth A. Foon,Hyman B. Muss Sin vista previa disponible - 2012 |
Términos y frases comunes
acid activity adjuvant adjuvant tamoxifen advanced breast cancer agents agonist androgen anti-Id antiandrogen antibody antiestrogens antigen aromatase inhibitor autologous binding breast cancer breast cancer cells breast cancer patients breast cancer survivors breast carcinoma breast tumors Cancer Res carcinogenesis castration cell lines chemopreventive chemotherapy Clin Oncol clinical trials colorectal cancer demonstrated disease dose effects of tamoxifen endocrine therapy endometrial cancer endometrial carcinoma endometrium ER-positive estradiol estrogen receptor fenretinide fluorouracil flutamide gene genistein growth factor hairy cell leukemia hormonal therapy human breast cancer immunotherapy induced inhibition interferon interferon-alpha levels melanoma menopausal metastatic metastatic breast cancer mg/day node-negative NSABP Obstet Gynecol Oncology ovarian ablation overall survival phase postmenopausal women premenopausal women prevention progesterone progestin prostate cancer protein randomized trial receiving tamoxifen recurrent replacement therapy response rates risk significant steroid surgical tamoxifen tamoxifen therapy tamoxifen-treated tissue toxicity transcription treated treatment tumor cells Urol vaccine versus vitro
Pasajes populares
Página 278 - O'Malley, BW (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.